Subcallosal Cingulate Cortex Deep Brain Stimulation for Treatment-Resistant Depression: A Systematic Review
Open Access
- 1 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 780481
Abstract
Background: Deep brain stimulation (DBS) is considered a relatively new and still experimental therapeutic modality for treatment-resistant depression (TRD). There is clinical evidence to suggest that stimulation of the subcallosal cingulate cortex (SCC) involved in the pathogenesis of TRD may exert an antidepressant effect. Aims: To conduct a systematic review of current studies, such as randomized clinical trials (RCTs), open-label trials, and placebo-controlled trials, examining SCC DBS for TRD in human participants. Method: A formal review of the academic literature was performed using the Medical Literature, Analysis, and Retrieval System Online (MEDLINE) and Cochrane Central Register of Controlled Trials (CENTRAL) databases. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Suitable studies were screened and assessed based on patient characteristics, clinical outcomes, adverse events related to DBS, and the stereotactic technique used to guide the implantation of DBS electrodes. Results: The literature search identified 14 clinical studies that enrolled a total of 230 patients with TRD who underwent SCC DBS. The average duration of follow-up was 14 months (range 6–24 months). The response and remission rates at the last available follow-up visit ranged between 23–92% and 27–66.7%, respectively. Conclusion: The current results of SCC DBS are limited by the relatively small number of patients treated worldwide. Nevertheless, studies to date suggest that SCC can be a promising and efficacious target for DBS, considering the high response and remission rates among patients with TRD. The adverse events of SCC DBS are usually transient and stimulation-induced.Keywords
This publication has 46 references indexed in Scilit:
- The expanding evidence base for rTMS treatment of depressionCurrent Opinion in Psychiatry, 2013
- Cross-species affective functions of the medial forebrain bundle—Implications for the treatment of affective pain and depression in humansNeuroscience & Biobehavioral Reviews, 2011
- Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorderCurrent Medical Research and Opinion, 2010
- Remission of Major Depression Under Deep Brain Stimulation of the Lateral Habenula in a Therapy-Refractory PatientBiological Psychiatry, 2010
- Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responsesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009
- Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant DepressionBiological Psychiatry, 2008
- A Patient with a Resistant Major Depression Disorder Treated with Deep Brain Stimulation in the Inferior Thalamic PeduncleNeurosurgery, 2005
- Deep Brain Stimulation for Treatment-Resistant DepressionNeuron, 2005
- Subgenual prefrontal cortex abnormalities in mood disordersNature, 1997
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986